Literatur
- 1
Evans R C, Fear S, Ashby D. et al .
Diet and colorectal cancer: an investigation of the
lectin/galactose
hypothesis.
Gastroenterology.
2002;
122
1784-1792
- 2
Martinez M E, Giovannucci E, Spiegelman D. et al .
Leisure-time physical activity, body size, and colon cancer
in women.
Nurses’ Health Study Research Group J Natl Cancer
Inst.
1997;
89
948-955
- 3
Shephard R J, Futcher R.
Physical activity and cancer: how may protection be
maximized?.
Crit Rev
Oncog.
1997;
8
219-272
- 4
Michels K B, Giovannucci E, Joshipura K J. et al .
Prospective study of fruit and vegetable consumption and
incidence of colon and rectal cancers.
J Natl Cancer
Inst.
2000;
92
1740-1752
- 5
Kono S, Hirohata T.
Nutrition and stomach cancer.
Cancer Causes
Control.
1996;
7
41-55
- 6
Botterweck A A, van
den
Brandt P A, Goldbohm R A.
A prospective cohort study on vegetable and fruit consumption
and stomach cancer risk in The Netherlands.
Am J
Epidemiol.
1998;
148
842-853
- 7
Fuchs C S, Willett W C, Colditz G A. et al .
The influence of folate and multivitamin use on the familial
risk of colon cancer in women.
Cancer Epidemiol Biomarkers
Prev.
2002;
11
227-234
- 8
Willett W C.
Diet and Cancer.
The
Oncologist.
2000;
5
393-404
- 9
Baron J A, Beach M, Mandel J S. et al .
Calcium Supplements for the Prevention of Colorectal
Adenomas.
N Engl J
Med.
1999;
340
101-107
- 10
Garland C F, Garland F C, Gorham E D.
Calcium and Vitamin D: Their Potential Roles in Colon and
Breast Cancer Prevention Ann.
N.Y. Acad.
Sci.
1999;
889
107-119
- 11
Wu K, Willett W C, Fuchs C S. et al .
Calcium Intake and Risk of Colon Cancer in Women and
Men.
J Natl Cancer
Inst.
2002;
94
437-446
- 12
Hyman J, Baron J A, Dain B J. et al .
Dietary and supplemental calcium and the recurrence of
colorectal adenomas.
Cancer Epidemiol Biomarkers
Prev.
1998;
7
291-295
- 13
Giovannucci E, Rimm E B, Stampfer M J. et al .
Intake of fat, meat, and fiber in relation to risk of colon
cancer in men.
Cancer
Res.
1994;
54
2390-2397
- 14
Goldbohm R A, van den
Brandt P A, van ‘t V eer
P. et al .
A prospective cohort study on the relation between meat
consumption and the risk of colon cancer.
Cancer
Res.
1994a;
54
718-723
- 15
et al .
Kampman E, Slattery ML, Bigler J.
Meat Consumption,
Genetic Susceptibility, and Colon Cancer Risk: A United States Multicenter
Case-Control Study Cancer Epidemiol Biomarkers
Prev.
1999;
8
15-24
- 16
Thun M J, Calle E E, Namboodiri M M. et al .
Risk factors for fatal colon cancer in a large prospective
study.
J Natl Cancer
Inst.
1992;
84
1491-1500
- 17
Willett W C, Stampfer M J, Colditz G A. et al .
Relation of meat, fat, and fiber intake to the risk of colon
cancer in a prospective study among women.
N Engl J
Med.
1990;
323
1664-1672
- 18
Bartsch H, Nair J, Owen R W.
Dietary polyunsaturated fatty acids and cancers of the breast
and colorectum: emerging evidence for their role as risk
modifiers.
Carcinogenesis.
1999;
20
2209-2218
- 19
Garfinkel L.
Overweight and
mortality.
Cancer.
1986;
58
1826-1829
- 20
Giovannucci E, Colditz G A, Stampfer M J. et al .
Physical activity, obesity, and risk of colorectal adenoma in
woman (United States).
Cancer Causes
Control.
1996;
7
253-263
- 21
Fuchs C S, Willett W C, Colditz G A. et al .
The influence of folate and multivitamin use on the familial
risk of colon cancer in women.
Cancer Epidemiol Biomarkers
Prev.
2002;
11
227-234
- 22
Goldbohm R A, Van den
Brandt P A, Van
‘t P Veer. et al .
Prospective study on alcohol consumption and the risk of
cancer of the colon and rectum in the Netherlands.
Cancer Causes
Control.
1994b;
5
95-104
- 23
Potter J D.
Nutrition and colorectal cancer.
Cancer Causes
Control.
1996;
7
127-146
- 24
Tavani A, Pregnolato A, La V ecchia
C.
Coffee and tea intake and risk of cancers of the colon and
rectum: a study of 3,530 cases and 7,057 controls.
Int J
Cancer.
1997;
73
193-197
- 25
Kim I Y, Baik H W, Fawaz K. et al .
Effects of folate supplementation on two provisional
molecular makers: a prospective, randomized trail.
.
Am J
Gastroenterol.
2001;
96
184-195
- 26
Giovannucci E, Rimm E B, Ascherio A. et al .
Alcohol, low-methionine-low-folate diets, and risk of colon
cancer in men.
J Natl Cancer
Inst.
1995;
87
265-273
- 27
Fuchs C S, Willett W C, Colditz G A. et al .
The influence of folate and multivitamin use on the familial
risk of colon cancer in women.
Cancer Epidemiol Biomarkers
Prev.
2002;
11
227-234
- 28
Giovannucci V, Stampfer M J, Colditz G A. et al .
Multivitamin use, folate, and colon cancer in women in the
Nurses’ Health Study.
Ann Intern
Med.
1998;
129
517-524
- 29
White E, Shannon J S, Patterson R E.
Relationship between vitamin and calcium supplement use and
colon cancer.
Cancer Epidemiol Biomarkers
Prev.
1997;
6
769-774
- 30
Giovannucci V, Stampfer M J, Colditz G A. et al .
Multivitamin use, folate, and colon cancer in women in the
Nurses’ Health Study.
Ann Intern
Med.
1998;
129
517-524
- 31
Clark L C, Combs G F
Jr, Turnbull B W. et al .
Effects of selenium supplementation for cancer prevention in
patients with carcinoma of the skin. A randomized controlled trial. Nutritional
Prevention of Cancer Study
Group.
JAMA.
1996;
276
1957-1963
- 32
Ghadirian P, Maisonneuve P, Perret C. et al .
A case-control study of toenail selenium and cancer of the
breast, colon, and prostate.
Cancer Detect
Prev.
2000;
24
305-313
- 33
Willett W C.
Diet and Cancer.
The
Oncologist.
2000;
5
393-404
- 34
Levi F, Pasche C, Lucchini F. et al .
Selected micronutrients and colorectal cancer. a case-control
study from the canton of Vaud, Switzerland.
Eur J
Cancer.
2000;
36
(16)
2115-2119
- 35
Heijnen M L, van
Amelsvoort J M, Deurenberg P. et al .
Limited effect of consumption of uncooked (RS2) or
retrograded (RS3) resistant starch on putative risk factors for colon cancer
in
healthy men Am.
J. Clinical
Nutrition.
1998;
67
322-331
- 36
Hylla S, Gostner A, Dusel G. et al .
Effects of resistant starch on the colon in healthy
volunteers: possible implications for cancer prevention.
Am. J.
Clinical
Nutrition.
1998;
67
136-142
- 37
The Alpha-Tocopherol, Beta Carotene Cancer Prevention
Study Group .
The effect of vitamin E and beta carotene on the incidence of
lung cancer and other cancers in male smokers.
N Engl J
Med.
1994;
330
1029-1035
- 38
Calle E E, Miracle-McMahill H L, Thun M J. et al .
Estrogen replacement therapy and risk of fatal colon cancer
in a prospective cohort of postmenopausal women.
J Natl Cancer
Inst.
1995;
87
517-523
- 39
Grodstein F, Newcomb P A, Stampfer M J.
Postmenopausal hormone therapy and the risk of colorectal
cancer: a review and meta-analysis.
Am J
Med.
1999;
106
574-582
- 40
Slattery M L, Potter J D, Curtin K. et al .
Estrogens Reduce and Withdrawal of Estrogens Increase Risk of
Microsatellite Instability-positive Colon Cancer.
Cancer
Res.
2001;
61
126-130
- 41
Morris C D, Armstrong G R, Bigley G. et al .
Cyclooxygenase-2 expression in the BarrettŽs
metaplasia-dysplasia-adenocarcinoma sequence.
Am J
Gastroenterol.
2001;
96
990-996
- 42
Kokawa A, Kondo H, Gotoda T. et al .
Increased expression of cyclooxgenase-2 in human pancreatic
neoplasms and potential for chemoprevention by cyclooxygenase
inhibitors.
Cancer.
2001;
91
333-338
- 43
Kawamori T, Rao C V, Seibert K. et al .
Chemopreventive activity of celecoxib, a specific
cyclooxygenase-2 inhibitor, against colon carcinogenesis.
Cancer
Res.
1998;
58
409-412
- 44
Jacoby R F, Seibert K, Cole C E. et al .
The cyclooxygenase-2 inhibitor celecoxib is a potent
preventive and therapeutic agent in the min mouse model of adenomatous
polyposis.
Cancer
Res,.
2000;
60
5040-5044
- 45
Oshima M, Dinchuk J E, Kargman S L. et al .
Suppression of intestinal polyposis in APC delta716 knockout
mice by inhibition of cyclooxygenase 2
(COX-2).
Cell.
1996;
87
803-809
- 46
Giardiello F M, Hamilton S R, Krush A J. et al .
Treatment of colonic and rectal adenomas with sulindac in
familial adenomatous polyposis.
N Engl J
Med.
1993;
328
1313-1316
- 47
Labayle D, Fischer D, Vielh P. et al .
Sulindac causes regression of rectal polyps in familial
adenomatous
polyposis.
Gastroenterology.
1991;
101
635-639
- 48
Nugent K P, Farmer K C, Spigelman A D. et al .
Randomized controlled trial of the effect of sulindac on
duodenal and rectal polyposis and cell proliferation in patients with familial
adenomatous polyposis.
Br J
Surg.
1993;
80
1618-1619
- 49
Steinbach G, Lynch P M, Phillips R K. et al .
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in
familial adenomatous polyposis.
N Engl J
Med.
2000;
342
1946-1952
- 50
Giardiello F M, Yang V W, Hylind L M. et al .
Primary chemoprevention of familial adenomatous polyposis
with sulindac.
N Engl J Med.
2002;
346
(4)
1054-1059
- 51
Yin M J, Yamamoto Y, Gaynor R B.
The anti-inflammatory agents aspirin and salicylate inhibit
the activity of I(kappa)B
kinase-beta.
Nature.
1998;
396
77-80
- 52
Stark L A, Din F V, Zwacka R M. et al .
Aspirin-induced activation of the NF-kappaB signaling
pathway: a novel mechanism for aspirin-mediated apoptosis in colon cancer
cells.
FASEB
J.
2001;
15
1273-1275
- 53
Tegeder I, Pfeilschifter J, Geisslinger G.
Cyclooxygenase-independent actions of cyclooxygenase
inhibitors.
FASEB
J.
2001;
15
2057-2072
- 54 Shimada T, Kojima K, Yoshiura K. et al .Characteristics of the peroxisome proliferator
activated
receptor nnn (PPARnnn) ligand induced apoptosis in colon cancer
cells. Gut 2002 50: 658-664
- 55
Sarraf P, Mueller E, Smith W M. et al .
Loss-of-function mutations in PPAR gamma associated with
human colon cancer.
Mol
Cell.
1999;
3
799-804
- 56 Gupta R A, Tan J, Krause W F. et al .Prostacyclin-mediated activation of peroxisome
proliferator-activated recepor d in colorectal
cancer. PNAS 2000 97: 13275-13280
- 57
Park B H, Vogelstein B, Kinzler K W.
Genetic disruption of PPAR delta decreases the tumorigenicity
of human colon cancer
cells.
PNAS.
2001;
98
2598-2603
- 58
Zhang L, Yu J, Park B H. et al .
Role of Bax in the apoptotic response to anticancer
agents.
Science.
2000;
290
989-992
- 59
Zhou X M, Wong B C, Fan X M. et al .
Non-steroidal anti-inflammatory drugs induce apoptosis in
gastric cancer cells through up-regulation of bax and
bak.
Carcinogenesis.
2001;
22
1393-1397
- 60
Farrow D C, Vaughan T L, Hansten P D. et al .
Use of aspirin and other nonsteroidal anti-inflammatory drugs
and risk of esophageal and gastric cancer.
Cancer Epidemiol
Biomarkers
Prev.
1998;
7
97-102
- 61
Akre K, Ekstrom A M, Signorello L B. et al .
Aspirin and risk for gastric cancer. A population-based
case-control study in Sweden.
Br J
Cancer.
2001;
84
965-968
- 62
Farrow D C, Vaughan T L, Hansten P D. et al .
Use of aspirin and other nonsteroidal anti-inflammatory drugs
and risk of esophageal and gastric cancer.
Cancer Epidemiol
Biomarkers
Prev.
1998;
7
97-102
- 63
Anderson K E, Johnson T W, Lazovich D. et al .
Association Between Nonsteroidal Anti-Inflammatory Drug Use
and the Incidence of Pancreatic Cancer
JNCI.
2002;
94
1168-1171
- 64
Suleiman S, Rex D K, Sonnenberg A.
Chemoprevention of colorectal cancer by aspirin: a
cost-effectiveness
analysis.
Gastroenterology.
2002;
122
78-84
- 65
Langman M J, Cheng K K, Gilman E A. et al .
Effect of anti-inflammatory drugs on overall risk of common
cancer: case-control study in general practice research
database.
BMJ.
2000;
320
1642-1646
G. Adler
Abt. Innere Medizin I, Medizinische Universitätsklinik
Robert-Koch-Straße 8
89081 Ulm
